Eris Lifesciences Limited (BOM:540596)

India flag India · Delayed Price · Currency is INR
1,720.25
+25.75 (1.52%)
At close: Aug 8, 2025
1.52%
Market Cap234.98B
Revenue (ttm)29.35B
Net Income (ttm)3.87B
Shares Outn/a
EPS (ttm)28.36
PE Ratio60.79
Forward PE39.29
Dividend7.35 (0.41%)
Ex-Dividend DateFeb 13, 2025
Volume3,066
Average Volume5,393
Open1,695.00
Previous Close1,694.50
Day's Range1,689.20 - 1,743.55
52-Week Range1,120.35 - 1,909.55
Betan/a
RSI45.34
Earnings DateAug 4, 2025

About Eris Lifesciences

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electro... [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 3,354
Stock Exchange Bombay Stock Exchange
Ticker Symbol 540596
Full Company Profile

Financial Performance

In 2024, Eris Lifesciences's revenue was 28.79 billion, an increase of 44.59% compared to the previous year's 19.91 billion. Earnings were 3.52 billion, a decrease of -10.26%.

Financial Statements

News

There is no news available yet.